ALR Technologies and Aspire Cerebro Advertising have inked a marketing deal in India for the ALRT diabetes management system. Aspira Cerebro Advertising plans to create a comprehensive marketing plan for the ALRT Diabetes Solution system, with the intent of bringing the technology to India’s estimated 100 million diabetes patients. “Our model enables pharmaceutical companies to […]
Alrtechnologies
ALR Technologies’ insulin dose adjustment feature wins FDA approval
ALR Technologies said today that the FDA approved the insulin dose adjustment feature of its ALRT diabetes management system. The ALRT system uses insulin dosing guidelines from the American Association of Clinical Endocrinologists and American Diabetes Association as reference doses. The reference doses are compared with a patient’s current insulin dose to decide if a patient’s […]